No therapeutic justification: Central Government bans 14 FDCs for human use Susmita Roy3 Jun 2023 1:31 PM ISTNew Delhi: In accordance with the recommendation, "no therapeutic justification" made by the Expert Committee and the Drugs Technical Advisory Board,...
Alkem Gets CDSCO Panel Nod To Manufacture, Market Linagliptin, Dapagliflozin antidiabetic FDC Dr. Divya Colin2 Jun 2023 6:00 PM ISTNew Delhi: The drug major Alkem Health Sciences has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Dr. Reddy's Gets CDSCO Panel Nod to study gastric acid blocker Vonoprazan fumarate Dr. Divya Colin1 Jun 2023 6:00 PM ISTNew Delhi: In line with the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
AstraZeneca gets CDSCO panel nod to Market Dapagliflozin to treat heart failure in adult Dr. Divya Colin31 May 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
CDSCO Issues Medical Device Alert For HOYA Vivinex iSert Toric IOLs Susmita Roy30 May 2023 6:00 PM ISTNew Delhi: Following the recall action notification for Hoya Vivinex isert Toric Intraocular Lens (IOLs) from the Department of Health, Therapeutics...
Rocky Road to E-Pharmacy Regulations Farhat Nasim29 May 2023 7:47 PM ISTNew Delhi: With the Centre proceeding towards formation of rules and regulations to regulate the online sale of medicines across the country,...
Akum Gets CDSCO Panel Nod to Study Antidiabetic FDC Drug Dr. Divya Colin28 May 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceuticals has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
Dr Reddy's Gets CDSCO Panel Nod to Market Sumatriptan Nasal Spray to treat acute migraine attacks Dr. Divya Colin27 May 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization(CDSCO) has granted approval to drug major...
Dr Reddy's Gets CDSCO Panel Nod to Manufacture, Market Anticancer Drug Lenalidomide Capsules Dr. Divya Colin26 May 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Dr. Reddy's Laboratories has got a green signal from the Subject Expert Committee (SEC)...
AstraZeneca Gets CDSCO Panel Nod To study COPD Drug Tozorakimab Dr. Divya Colin25 May 2023 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
Indian Pharma Market registers 11 percent growth in April: IQVIA Farhat Nasim24 May 2023 11:51 AM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has reported double-digit growth of 11 percent for the month of April 2023, according to IQVIA.On a...
MSD Pharma Gets CDSCO Panel Nod for additional indication of anticancer drug Pembrolizumab Dr. Divya Colin23 May 2023 6:00 PM ISTNew Delhi: Based on the global clinical trial data presented by drug major, MSD Pharmaceuticals, the Subject Expert Committee (SEC) functional under...
